Merz Aesthetics has revamped its…
Merz Aesthetics has revamped its sales and marketing leadership, promoting [...]
Merz Aesthetics has revamped its sales and marketing leadership, promoting [...]
The administration has not put forward a clear legal authority [...]
GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic [...]
Allogene Therapeutics has reported a patient death tied to its [...]
After the surprise departure of longtime CEO Lars Fruergaard Jørgensen [...]
The latest move by President Donald Trump to try to [...]
Merck will reduce its workforce by approximately 6,000 employees in [...]
A PD-L1xVEGF bispecific antibody from China’s ImmuneOnco Biopharmaceuticals has shown [...]
AbbVie is ending development of an IL-1 asset as a [...]
Nuvectis Pharma has dropped plans to develop NXP800 in ovarian [...]